Results of a Randomized Phase II Trial of Pegfilgrastim Versus Filgrastim To Treat Neutropenia Post-Autologous Peripheral Blood Stem Cell Transplant (PBSCT) in Patients with Non-Hodgkin's Lymphoma (NHL).
- Resource Type
- Abstract
- Source
- In
Blood 16 November 2007 110(11):4936-4936 - Subject
- Language
- ISSN
- 0006-4971